BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 18, 2020
View Archived Issues
Pfizer studies PF-06939926 in phase III for DMD
Read More
Pfizer conducts phase I study of PF-07248144 in advanced or metastatic solid tumors
Read More
Psychedelic analogue has therapeutic potential
Read More
Discovery and preclinical evaluation of a new sGC stimulator for hypertension treatment
Read More
ONK Therapeutics signs option license agreements to strengthen NK cell therapy pipeline
Read More
Phase II data on AB-023 support use in prevention of device-associated thrombosis
Read More
Chordia Therapeutics reports preclinical data for MALT1 inhibitor
Read More
Vasomune initiates first-in-human study of AV-001 as potential therapy for COVID-19 and ARDS
Read More
Phase I/II data shows therapeutic activity of OTO-413 across multiple speech-in-noise hearing tests
Read More
Benlysta approved as the first therapy for adult patients with active lupus nephritis in the U.S.
Read More
HSF1 inhibition directly targets treatment-resistant prostate cancer
Read More
Results from first-in-human trial of BCMA-targeted ADC MEDI-2228 presented
Read More
VioGen Biosciences patents new PIKfyve inhibitors
Read More
Agios Pharmaceuticals synthesizes new MAT2A inhibitors
Read More
Angex Pharmaceutical presents new PRMT5 inhibitors
Read More
Ideaya Biosciences discloses POLH inhibitors
Read More
STP-938, a novel CTPS1 inhibitor with activity in hematological malignancies
Read More
New hMPV-derived vaccines presented by Valneva
Read More
Phase II trials of ALX-629 begin in COVID-19, atopic asthma and psoriasis
Read More
EDP-1503 plus pembrolizumab safe and well-tolerated in TNBC patients
Read More
First-in-human data presented for AB-928 with or without IPI-549 in patients with cancer
Read More
Albireo starts phase III trial of odevixibat in Alagille syndrome
Read More
Shionogi initiates phase I/II study in Japan with COVID-19 vaccine candidate
Read More
FDA clears IND for AlloVir's ALVR-106 to treat severe respiratory viral infections
Read More